Unilabs Reports Second Quarter 2015 Financial Results
Unilabs announced further growth today, reporting that for the quarter ending 30 June 2015, revenue was €172.1m, compared to €153.5m in Q2 2014.  The results show a significant and positive organic sales growth of 7.1% (CER†) leading to EBITDA growth vs Q2 2014 of 25.6%.  This marks the 4th successive quarter of revenue growth, EBITDA growth and cost savings.

More info in the News section
Unilabs Sweden confirms its status as Mammography Market Leader with renewal of the Skåne Contract
Unilabs has been fully responsible for women mammography screening for the region of Skane since 2009 and gets to renew the confidence of the Skåne region for another 5+2 years. The contract, that will start in April 2016, represents over €10.5M.

More info in the News section

Our Partnerships, Expertise & Network

We are a partner of choice and leading provider of outsourced diagnostic services with more than 200 diagnostic contracts across Europe.
Our services include: laboratory medicine, medical imaging, histopathology, reproductive medicine, and drug development services.
With operations in 11 countries, we are positioned as a regional leader with one of the broadest geographic coverage in Europe.